APOA1 and heart failure: These data are in agreement with the evidence that low HDL-cholesterol, apo-A1, and triglycerides levels correlate with adverse prognosis in patients with heart failure independent of the etiology (62–64), probably because apo-A1 may exert an anti-inflammatory action in HF (65).